OCULAR THERAPEUTIX INC (OCUL:NASDAQ)
$7.56 0.02 (0.2653%)
Analysed OCULAR THERAPEUTIX INC (OCUL:NASDAQ) News Sources
Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs
03-09-2026
yahoo.com
Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Success
23-09-2026
marketbeat.com
Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?
23-09-2026
yahoo.com
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
23-09-2026
yahoo.com
OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs
28-09-2026
stocktwits.com
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
01-10-2026
yahoo.com
OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD
01-10-2026
stocktwits.com
Ocular Therapeutix (OCUL) Stock Still Looks Pricey As 145% Gain Draws Scrutiny
02-10-2026
yahoo.com
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist
05-10-2026
stocktwits.com
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09-10-2026
yahoo.com
What is the current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is $7.56.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) absolute price change since previous trading day?
The absolute price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is $0.02.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) percentage price change since previous trading day?
The percentage price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is 0.2653%.
What is the most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is 45 out of 100.
What is the most recent average sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is .
SEC-8K** Filing Available For OCULAR THERAPEUTIX INC (OCUL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.